# Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis

> **NCT00017628** · PHASE1 · COMPLETED · sponsor: **Northwestern Memorial Hospital** · enrollment: 20 (—)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** cyclophosphamide
- **DRUG:** filgrastim
- **DRUG:** methylprednisolone
- **PROCEDURE:** Autologous Stem Cell Transplantation

## Key facts

- **NCT ID:** NCT00017628
- **Lead sponsor:** Northwestern Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-04
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00017628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00017628, "Phase I Study of High-Dose Cyclophosphamide and Total Body Irradiation With T Lymphocyte-Depleted Autologous Peripheral Blood Stem Cell or Bone Marrow Rescue in Patients With Multiple Sclerosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00017628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*